跳至主要内容
临床试验/NCT01594697
NCT01594697已完成不适用

Metformin in Pregnancy in Women With Polycystic Ovary Syndrome

Catholic University of the Sacred Heart1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年5月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
incidence of gestational diabetes

研究概览

简要总结

The study provide a detailed longitudinal evaluation of the gluco-insulinemic assessment of pregnant PCOS women under metformin treatment. 47 non diabetic Polycystic Ovary Syndrome (PCOS) women became pregnant during metformin treatment and continued taking the drug during gestation. An oral glucose tolerance test and euglycaemic hyperinsulinaemic clamp were performed at each trimester of gestation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • age 18-40 yr,
  • metformin treatment for at least 3 months before entering the pregnancy,
  • gestational age between 5 and 12 wk

排除标准

  • diabetes mellitus
  • significant liver or renal impairment
  • neoplasms and other endocrine diseases
  • the use of drugs other than metformin able to interfere with glucose and insulin metabolism.

研究组 & 干预措施

metformin

Experimental

干预措施: Metformin (Drug)

结局指标

主要结局

incidence of gestational diabetes

次要结局

  • number of newborns with macrosomia
  • rate of spontaneous abortion
  • number of hypertensive disorders
  • number of live births
  • incidence of delivery by caesarian section

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maurizio Guido

Principal Investigator

Catholic University of the Sacred Heart

研究点 (1)

Loading locations...

相似试验

已完成
3 期
Metformin in Pregnant PCOS WomenPolycystic Ovary Syndrome
NCT00159536Norwegian University of Science and Technology257
已完成
2 期
Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot StudyPolycystic Ovary Syndrome
NCT03259919Norwegian University of Science and Technology40
进行中(未招募)
1 期
PregMet 2 studyPoly Cystic Ovarial Syndrome (PCOS) in pregnant women. PCOS should be diagnosed according to the Rotterdam Consensus criterias:- at least 2 out of 3 criterias1.PCO in at least one ovary2.Oligo-/anovulation (clinically diagnosed as oligo-/amenorrhea,i.e. menstrual cycles > 35 days or <10 menstruations/year3.Hyperandrogenismclinical or biochemicalMedDRA version: 14.1Level: LLTClassification code 10065161Term: Polycystic ovarian syndromeSystem Organ Class: 100000004872
EUCTR2011-002203-15-SETNU, Norwegian University of Science and Technology1,000
进行中(未招募)
1 期
PregMet 2 study
EUCTR2011-002203-15-ISTNU, Norwegian University of Science and Technology1,000
进行中(未招募)
1 期
PregMet 2 studyPoly Cystic Ovarial Syndrome (PCOS) in pregnant women. PCOS should be diagnosed according to the Rotterdam Consensus criterias: - at least 2 out of 3 criterias 1.PCO in at least one ovary 2.Oligo-/anovulation (clinically diagnosed as oligo-/amenorrhea,i.e. menstrual cycles > 35 days or <10 menstruations/year 3.Hyperandrogenismclinical or biochemicalMedDRA version: 20.0 Level: LLT Classification code 10065161 Term: Polycystic ovarian syndrome System Organ Class: 100000004872
EUCTR2011-002203-15-NOTNU, Norwegian University of Science and Technology1,000